Eli Lilly - Publications - Faculty & Research

13 Jan 2003
Research & Ideas

Making Biotech Work as a Business

influenced the industry by proving that intellectual property could be monetized through alliances with big pharmaceutical partners, according to Pisano. Genentech cut its first deal with Eli Lilly in 1982... View Details

Keywords: by Martha Lagace; Biotechnology; Health; Technology

06 Feb 2007
First Look

First Look: February 6, 2007

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707486 Corporate Venture Capital at Eli Lilly Harvard Business School Case 806-092 Reviews the role of corporate venture capital and its history... View Details

Keywords: Martha Lagace

20 Apr 2016
Research & Ideas

When CEOs Become Activists

which executive activism affected not only public opinion but also customer perceptions. Apple CEO Cook’s actions around the RFRA debate particularly intrigued the researchers. “You can see a business reason why the CEOs of Eli View Details

Keywords: by Carmen Nobel; Technology; Publishing

Web

Faculty & Advisors | MBA

Eli Lilly Canada, the Controller and Treasurer at Eli Lilly and Company and Chief Financial Officer at Cardinal Health. Lara Hodgson MBA ’98,... View Details

28 Apr 2009
First Look

First Look: April 28, 2009

the company submits to the Food and Drug Administration. The case reviews Targanta's origins and "de-risking" of oritavancin, an antibiotic therapy for drug-resistant infections that was first invented at Eli View Details

Keywords: Martha Lagace

18 Dec 2012
First Look

First Look: December 18

note:http://hbr.org/search/813096-PDF-ENG Cialis Lifecycle Management: Lilly's BPH Dilemma Ofek, Elie, and Natalie KindredHarvard Business School Case 513-005 How should Eli Lilly further develop and market... View Details

Keywords: Carmen Nobel

Publications